Dendritic cells derived from TBP-2-deficient mice are defective in inducing T cell responses

European Journal of Immunology

Volumn 38, Issue 5, 2008, Pages 1358-1367

  Son, Aoi ^a   Nakamura, Hajime ^b   Okuyama, Hiroaki ^b   Oka, Shin Ichi ^a   Yoshihara, Eiji ^a   Liu, Wenrui ^a   Matsuo, Yoshiyuki ^a   Kondo, Norihiko ^a   Masutani, Hiroshi ^a   Ishii, Yasuyuki ^c   Iyoda, Tomonori ^a   Inaba, Kayo ^a   Yodoi, Junji ^a,b  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

^c RIKEN Center for Integrative Medical Sciences   (Japan)

Author keywords

Dendritic Cell; T cell responses; Thioredoxin binding protein 2

Indexed keywords

B7 ANTIGEN; BINDING PROTEIN; CD40 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OVALBUMIN; THIOREDOXIN BINDING PROTEIN 2; UNCLASSIFIED DRUG; CARRIER PROTEIN; CYTOKINE; INTERLEUKIN 12; THIOREDOXIN; TXNIP PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL STIMULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; DENDRITIC CELL; FEMALE; FLOW CYTOMETRY; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; IN VIVO STUDY; LYMPHOCYTE ACTIVATION; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPERNATANT; T LYMPHOCYTE; WILD TYPE; ANIMAL; ANTIBODY PRODUCTION; BAGG ALBINO MOUSE; C57BL MOUSE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; GENE EXPRESSION; GENETICS; IMMUNOLOGY; METABOLISM; MIXED LYMPHOCYTE CULTURE; MOUSE MUTANT; PHYSIOLOGY;

ANIMALS; ANTIBODY FORMATION; CARRIER PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CYTOKINES; DENDRITIC CELLS; FEMALE; GENE EXPRESSION; HYPERSENSITIVITY, DELAYED; INTERLEUKIN-12; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; OVALBUMIN; T-LYMPHOCYTES; THIOREDOXINS;

EID: 47049124547     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200737939     Document Type: Article

References (32)

1. Nishiyama, A., Matsui, M., Iwata, S., Hirota, K., Masutani, H., Nakamura, H., Takagi, Y. et al., Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression. J. Biol. Chem. 1999. 274: 21645-21650.
2. Chen, K. S. and DeLuca, H. F., Isolation and characterization of a novel cDNA from HL-60 cells treated with 1,25-dihydroxyvitamin D-3. Biochim. Biophys. Acta 1994. 1219: 26-32.
3. Nishinaka, Y., Nishiyama, A., Masutani, H., Oka, S., Ahsan, K. M., Nakayama, Y., Ishii, Y. et al., Loss of thioredoxin-binding protein-2/vitamin D3 up-regulated protein 1 in human T-cell leukemia virus type I-dependent T-cell transformation: Implications for adult T-cell leukemia leukemogenesis. Cancer Res. 2004. 64: 1287-1292.
4. Ahsan, M. K., Masutani, H., Yamaguchi, Y., Kim, Y. C., Nosaka, K., Matsuoka, M., Nishinaka, Y. et al., Loss of interleukin-2-dependency in HTLV-I-infected T cells on gene silencing of thioredoxin-binding protein-2. Oncogene 2006. 25: 2181-2191.
5. Oka, S., Liu, W., Masutani, H., Hirata, H., Shinkai, Y., Yamada, S., Yoshida, T. et al., Impaired fatty acid utilization in thioredoxin binding protein-2 (TBP-2)-deficient mice: A unique animal model of Reye syndrome. FASEB J. 2006. 20: 121-123.
6. Bodnar, J. S., Chatterjee, A., Castellani, L. W., Ross, D. A., Ohmen, J., Cavalcoli, J., Wu, C. et al., Positional cloning of the combined hyperlipidemia gene Hyplip1. Nat. Genet. 2002. 30: 110-116.
7. Lee, K. N., Kang, H. S., Jeon, J. H., Kim, E. M., Yoon, S. R., Song, H., Lyu, C. et al., VDUP1 is required for the development of natural killer cells. Immunity 2005. 22: 195-208.
8. Hackstein, H. and Thomson, A. W., Dendritic cells: Emerging pharmacological targets of immunosuppressive drugs. Nat. Rev. Immunol. 2004. 4: 24-34.
9. Penna, G. and Adorini, L., 1Alpha, 25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J. Immunol. 2000. 164: 2405-2411.
10. Piemonti, L., Monti, P., Sironi, M., Fraticelli, P., Leone, B. E., Dal Cin, E., Allavena, P. and Di Carlo, V., Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J. Immunol. 2000. 164: 4443-4451.
11. Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y. J., Pulendran, B. and Palucka, K., Immunobiology of dendritic cells. Annu. Rev. Immunol. 2000. 18: 767-811.
12. Kapsenberg, M. L., Dendritic-cell control of pathogen-driven T-cell polarization. Nat. Rev. Immunol. 2003. 3: 984-993.
13. Gately, M. K., Renzetti, L. M., Magram, J., Stern, A. S., Adorini, L., Gubler, U. and Presky, D. H., The interleukin-12/ interleukin-12-receptor system: Role in normal and pathologic immune responses. Annu. Rev. Immunol. 1998. 16: 495-521.
14. Liu, Y. J., Kanzler, H., Soumelis, V. and Gilliet, M., Dendritic cell lineage, plasticity and cross-regulation. Nat. Immunol. 2001. 2: 585-589.
15. Ishli, T., Hishinuma, L., Bannai, S. and Sugita, Y., Mechanism of growth promotion of mouse lymphoma L1210 cells in vitro by feeder layer or 2-mercaptoethanol. J. Cell. Physiol. 1981. 107: 283-293.
16. Angelini, G., Gardella, S., Ardy, M., Ciriolo, M. R., Filoment G., Di Trapani, G., Clarke, F. et al., Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation. Proc. Natl. Acad. Sci. USA 2002. 99: 1491-1496.
17. Rutella, S., Danese, S. and Leone, G., Tolerogenic dendritic cells: Cytokine modulation comes of age. Blood 2006. 108: 1435-1440.
18. D'Ambrosio, D., Cippitelli, M., Cocciolo, M. G., Mazzeo, D., Di Lucia, P., Lang, R., Sinigaglia, F. and Panina-Bordignon, P., Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J. Clin. Invest. 1998. 101: 252-262.
19. Adorini, L., Giarratana, N. and Penna, G., Pharmacological induction of tolerogenic dendritic cells and regulatory T cells. Semin. Immunol. 2004. 16: 127-134.
20. Griffin, M. D., Lutz, W. H., Phan, V. A., Bachman, L. A., McKean, D. J. and Kumar, R., Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs. Biochem. Biophys. Res. Commun. 2000. 270: 701-708.
21. Griffin, M. D., Lutz, W., Phan, V. A., Bachman, L. A., McKean, D. J. and Kumar, R., Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: A vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc Natl. Acad. Sci. USA 2001. 98: 6800-6805.
22. Sato, K., Yamashita, N., Baba, M. and Matsuyama, T., Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells. Blood 2003. 101: 3581-3589.
23. Wakkach, A., Fournier, N., Brun, V., Breittmayer, J. P., Cottrez, F. and Groux, H., Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 2003. 18: 605-617.
24. Matsuzawa, A., Saegusa, K., Noguchi, T., Sadamitsu, C., Nishitoh, H., Nagai, S., Koyasu, S. et al., ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity. Nat. Immunol. 2005. 6: 587-592.
25. Matsue, H., Edelbaum, D., Shalhevet, D., Mizumoto, N., Yang, C., Mummert, M. E., Oeda, J. et al., Generation and function of reactive oxygen species in dendritic cells during antigen presentation. J. Immunol. 2003. 171: 3010-3018.
26. Verhasselt, V., Goldman, M. and Willems, F., Oxidative stress up-regulates IL-8 and TNF-alpha synthesis by human dendritic cells. Eur. J. Immunol. 1998. 28: 3886-3890.
27. Rutault, K., Alderman, C., Chain, B. M. and Katz, D. R., Reactive oxygen species activate human peripheral blood dendritic cells. Free Radic. Biol. Med. 1999. 26: 232-238.
28. Chutkow, W. A., Patwari, P., Yoshioka, J. and Lee, R. T., Thioredoxin-interacting protein (Txnip) is a critical regulator of hepatic glucose production. J. Biol. Chem. 2008. 283: 2397-2406.
29. Lutz, M. B., Kukutsch, N., Ogilvie, A. L., Rossner, S., Koch, F., Romani, N. and Schuler, G., An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 1999. 223: 77-92.
30. Son, A., Nakamura, H., Kondo, N., Matsuo, Y., Liu, W., Oka, S., Ishii, Y. and Yodoi, J., Redox regulation of mast cell histamine release in thioredoxin-1 (TRX) transgenic mice. Cell Res. 2006. 16: 230-239.
31. Goh, K. C., deVeer, M. J. and Williams, B. R., The protein kinase PKR is required for p38 MAPK activation and the innate immune response to bacterial endotoxin. EMBO J. 2000. 19: 4292-4297.
32. Ilangumaran, S., Finan, D., Raine, J. and Rottapel, R., Suppressor of cytokine signaling 1 regulates an endogenous inhibitor of a mast cell protease. J. Biol. Chem. 2003. 278: 41871-41880.